Norwegian version of this page

The Waszak Group

The Computational Oncology Group at the Centre for Molecular Medicine Norway (NCMM) focuses on precision medicine for children with brain tumors. The group is led by Dr. Sebastian Waszak.

Image may contain: Line, Circle, Symmetry.

Image: Shutterstock







We develop computational and experimental approaches to understand the genetic basis of cancer, the somatic evolution of cancer cells, and molecular mechanisms that drive tumor growth. Our long-term aim is to improve diagnosis, prognosis, and therapeutic recommendations for young patients with cancer, in particular children with aggressive brain tumors. Our current focus is centered around the following research topics:

•    Origin and evolution of malignant brain tumors in children
•    Development of new approaches for rapid diagnostics of pediatric brain tumors
•    Precision medicine for patients with pediatric-type diffuse high-grade gliomas

Visit the Computational Oncology group's external website for further information.

Published Apr. 15, 2020 12:52 PM - Last modified Nov. 28, 2022 9:20 AM